Researchers have discovered a potential risk of cancer associated with the use of the heartburn drug, Zantac. The drug and its generic form ranitidine appear to cause chemical reactions which can produce N-nitrosodimethylamine (NDMA). NDMA has been identified as a probable human carcinogen.
The Discovery of Zantac’s Dangers
Zantac is one of the most popular heartburn treatment drugs available today. People worldwide have relied on the medication for years to ease the pain of heartburn.
As the NDMA situation has developed, several theories have been presented as to why the drug appears to cause cancer. At first, many people believed the presence of NDMA was due to contamination during manufacturing, as was the case earlier in the year when blood pressure medication was found to contain NDMA. However, it was later stated by the online pharmacy Valisure that the NDMA in Zantac can be attributed to the chemical reactions of ranitidine. The United States Food and Drug Administration (FDA) is conducting tests into the presence of NDMA in Zantac and the cause of the issue.
Diagnoses, Recalls, and Lawsuits
The use of Zantac is primarily associated with cancers of the stomach, intestines, kidneys, liver, bladder, and other digestive organs.
In response to the NDMA findings, Zantac was recalled by its manufacturers and pulled from store shelves by major retailers including Walgreens, CVS, Kroger, Target, Rite-Aid, and Walmart.
Patients who frequently use Zantac or similar drugs should consult with their doctor before considering alternative forms of treatment. Although there is a risk associated with the drug, it is important to discuss those risks with a medical professional before making any changes that could impact your health. There are many heartburn treatment drugs that do not contain ranitidine and could potentially work for you.
People who developed cancer caused by regular Zantac use may be interested in pursuing compensation through a lawsuit. The link between ranitidine, NDMA, and cancer has inspired legal action across the country.
If you developed cancer and believe your diagnosis is linked to the use of Zantac and other ranitidine drugs, the Tate Law Group, LLC legal team may be able to help. Contact our firm to discuss your case.
Complete our contact formor call (912) 234-3030 to schedule a free consultation with our lawyers.